CAT

CATO SMS

CATO SMS is a global provider of specialized clinical research solutions that advance drug development for small and emerging biopharmaceutical companies. The company offers a comprehensive portfolio of solutions, including product development consulting, biostatistical services, clinical pharmacology and full-service clinical trial operations. CATO SMS stands out for its strength in supporting development in complex therapeutic areas, including oncology, rare and orphan indications, and cell and gene therapy. The company was formed in 2019 when Cato Research merged with SMS-oncology. Working with Water Street, CATO SMS has completed additional strategic acquisitions and organic initiatives to deepen its oncology and regulatory expertise, expand its suite of solutions and broaden its global network.

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link, news@waterstreet.com.

Something went wrong. If you are seeing this error, please let us know, and we will get it fixed asap.